HydroxycarbamideDel (5q)-positive myelodysplastic syndrome: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2017年 / 1647卷 / 1期
关键词：
D O I：
10.1007/s40278-017-28848-y
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：156 / 156
相关论文
共 50 条
  • [21] Pathophysiology and treatment of the myelodysplastic syndrome with isolated 5q deletion
    Jadersten, Martin
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (03): : 348 - 351
  • [22] Suspected Immune Thrombocytopenic Purpura Induced by Lenalidomide for the Treatment of Myelodysplastic Syndrome with Deletion of Chromosome 5q: A Case Report
    Furukawa, Haruna
    Nomura, Jun
    Kobayashi, Masahiro
    Abe, Shori
    Takeda, Tomoki
    Oka, Yumiko
    Shirota, Yuko
    Kodera, Takao
    Okitsu, Yoko
    Takahashi, Shinichiro
    Murakami, Keigo
    Kameoka, Junichi
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2023, 259 (02): : 113 - 119
  • [23] Autoimmune disorders in two patients with myelodysplastic syndrome and 5q deletion
    Giagounidis, AAN
    Haase, S
    Germing, U
    Heinsch, M
    Aul, C
    ACTA HAEMATOLOGICA, 2005, 113 (02) : 146 - 149
  • [24] SURVIVAL OF PATIENTS WITH DE NOVO MYELODYSPLASTIC SYNDROME AND del(5q)
    Gritsaev, S. V.
    Martynkevich, I. S.
    Petrova, E. V.
    Martynenko, L. S.
    Kostroma, I. I.
    Ivanova, M. P.
    Tsybakova, N. Yu.
    Kozlovskaya, M. A.
    Sergeyev, A. N.
    Tiranova, S. A.
    Potikhonova, N. A.
    Abdulkadyrov, K. M.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2013, 58 (01): : 3 - 9
  • [25] A paediatric myelodysplastic syndrome with 5q deletion associated with Fanconi anaemia
    Kornreich, Laure
    Soulier, Jean
    Grange, Beatrice
    Girard, Sandrine
    Ouchee-Chardin, Marie
    Ceraulo, Antony
    PEDIATRIC BLOOD & CANCER, 2020, 67 (07)
  • [26] AntineoplasticsIsolated del(5q), myelodysplastic syndrome and acute myeloid leukaemia: 15 case reports
    Reactions Weekly, 2016, 1584 (1) : 29 - 29
  • [27] A Case of Refractory Thrombocytopenia with 5q Deletion: Myelodysplastic Syndrome Mimicking Idiopathic Thrombocytopenic Purpura
    Chang, Jeonghyun
    Park, Chan-Jeoung
    Seo, Eul-Ju
    Lee, Jung-Hee
    Park, Sang Hyuk
    Cho, Young-Uk
    Jang, Seongsoo
    ANNALS OF LABORATORY MEDICINE, 2014, 34 (06) : 466 - 468
  • [28] Lenalidomide in 5q minus myelodysplastic syndrome: how long is enough?
    Donat Dürr
    Raffaele Daniele Siciliano
    Yvonne Hummel
    Alix O’Meara
    Anita Hirschi
    Roger Burkhard
    Hanspeter Honegger
    Annals of Hematology, 2010, 89 : 105 - 106
  • [29] Mechanisms of Resistance to Lenalidomide in Del(5q) Myelodysplastic Syndrome Patients
    Martinez-Hoyer, Sergio
    Docking, Rod
    Chan, Simon
    Jadersten, Martin
    Parker, Jeremy
    Karsan, Aly
    BLOOD, 2015, 126 (23)
  • [30] CHARACTERIZATION OF THE TRANSCRIPTIONAL ALTERATIONS OF PATIENTS WITH DEL(5Q) MYELODYSPLASTIC SYNDROME
    Berastegui Zufiaurre, N.
    Serrano, G.
    Diaz Mazkiaran, A.
    Huerga, S.
    Garcia-Olloqui, P.
    Ainciburu, M.
    Alfonso, A.
    Vilas-Zornoza, A.
    San Martin, P.
    Lamo De Espinosa, J. M.
    Acha, P.
    Jimenez Solas, T.
    Molero, A.
    Montoro, M. J.
    Campelo, M.
    Valcarcel, D.
    Sole, F.
    Ochoa, I.
    Hernaez, M.
    Ezponda, T.
    Prosper, F.
    LEUKEMIA RESEARCH, 2023, 128
12345